| Pharmaceutical active ingredients: |
| HydrochlorothiazideSpironolactone |
| Available forms, composition and doses of Spironolactone; Hydrochlorothiazide: |
| Tablets; Oral; Hydrochlorothiazide 25 mg; Spironolactone 25 mg |
| Spironolactone; Hydrochlorothiazide medical category: |
| Human:Mineralocorticoid (Aldosterone) receptor antagonistsThiazide diuretics |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| C03DA01 - SpironolactoneC03EA01 - Hydrochlorothiazide and potassium-sparing agents |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Parke-Davis |